Abstract

Comprehensive genomic profiling with whole-genome sequencing has emerged as a promising approach for pediatric precision medicine. Recently, the Australian Zero Childhood Cancer Precision Medicine Program used this strategy and reported that more than 70% of children with cancer had potentially targetable genomic alterations-and almost a third of patients who received a matched therapy responded.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.